Vivet Therapeutics receives EUR 4 9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.